ArticleDrug design, development and therapy2022

Isoliquiritigenin Ameliorates Ischemia-Induced Myocardial Injury via Modulating the Nrf2/HO-1 Pathway in Mice.

Deshan Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.